MedPath

Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell Carcinoma

Completed
Conditions
Optical Enhancement Endoscopy
Artificial Intelligence
Magnifying Endoscopy
Registration Number
NCT03759756
Lead Sponsor
Shandong University
Brief Summary

Esophageal squamous cell carcinoma is one of the most common malignant tumor of upper digestive tract. However, the detection rate and diagnosis accuracy of early esophageal squamous cell cancer is low. The aim of this study is to develop a computer-assisted diagnosis tool combining with optical magnifying endoscopy for early detection and accurate diagnosis of it.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
119
Inclusion Criteria
  • high risk patients for esophageal cancer aged 18 years or older;
  • Histologically verified early esophageal squamous cell cancer.
Exclusion Criteria
  • patients whose images of esophagus not suitable for the training, validation and testing the computer-assist diagnosis tool.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the diagnosis efficiency of the AI model12 months

the sensitivity, specificity and accuracy of the AI model

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

🇨🇳

Jinan, Shandong, China

Department of Gastroenterology, Qilu Hospital, Shandong University
🇨🇳Jinan, Shandong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.